Tabula Rasa HealthCare® Expands Clinical Services for Patients Enrolled in Medicare Advantage
June 25 2020 - 08:00AM
Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:
TRHC), a healthcare technology company advancing the field
of medication safety, announced it is expanding its clinical
services to include special needs and high-risk patient populations
enrolled in Medicare Advantage. TRHC will assist health plans in
meeting the Care for Older Adults (COA) program requirements.
Starting with a large multi-state health plan, TRHC’s
SinfoniaRx® solution will begin providing medication reviews and
pain assessments for patients enrolled in Medicare Special Needs
Plans (SNPs), one type of a Medicare Advantage plan. Medicare SNPs
are supporting nearly 3.5 million Americans as of June 2020. The
intent of the COA measures is to ensure older adults enrolled in
these plans receive appropriate screenings and services.
“Managed care plans came to us for assistance in meeting quality
medication review requirements,” said TRHC Executive Vice President
Sandra Leal, PharmD, MPH, FAPhA. “Leveraging our skilled
pharmacists and medication safety technology, TRHC provides a
process that increases communication between patient and provider
by enabling medication safety information to be directly recorded
into an EHR after a medication review and assessment.”
TRHC services to meet COA measures are delivered through TRHC’s
RxCompanion™, a highly customizable and scalable platform that
identifies and helps resolve medication and health-related
problems. Through a population management approach, potential
problems are triaged based on urgency and complexity, then resolved
through telephonic, face-to-face or video-based consultations with
a pharmacist.
“Patients in Medicare Special Needs Plans now can receive a
personal medication list and medication action plan to help them
better understand and maintain their medications,” said TRHC
Chairman and CEO Calvin H. Knowlton, PhD. “Health plans in need of
assistance in meeting their Star Rating goals can be assured the
TRHC team of pharmacists will help health plans achieve
important quality measures.”
About Tabula Rasa HealthCareTabula Rasa
HealthCare (TRHC) is a leader in providing patient-specific,
data-driven technology and solutions that enable healthcare
organizations to optimize performance to improve patient outcomes,
reduce hospitalizations, lower healthcare costs, and manage risk.
Medication risk management is TRHC’s lead offering, and its
cloud-based software applications provide solutions for a range of
payers, providers and other healthcare organizations. For more
information, visit TRHC.com.
Forward-Looking Statement This press release
includes forward-looking statements that we believe to be
reasonable as of today’s date. Such statements are identified by
use of the words “anticipates,” “believes,” “estimates,” “expects,”
“intends,” “plans,” “predicts,” “projects,” “should,” and similar
expressions. These forward-looking statements are based on
management’s expectations and assumptions as of the date of this
press release. These forward-looking statements include, among
other things, our goals and expectations regarding the combined
company and the integration of PW into TRHC, the expected synergies
from the combined company and the expected financial and operating
performance of TRHC following the completion of the acquisition.
Actual results might differ materially from those explicit or
implicit in the forward-looking statements. Important factors that
could cause actual results to differ materially include: the risk
that we may not be able to achieve our expectations for the
combined companies due to challenges in integration and inability
to retain key employees; fluctuations in our financial results; the
acceptance and use of our products and services by PACE
organizations and pharmacies; the need to innovate and provide
useful products and services; risks related to changing healthcare
and other applicable regulations; our ability to maintain
relationships with a specified drug wholesaler; increasing
consolidation in the healthcare industry; managing our growth
effectively; our ability to adequately protect our intellectual
property; the requirements of being a public company; our ability
to recognize the expected benefits from acquisitions on a timely
basis or at all; and the other risk factors set forth from time to
time in our filings with the Securities and Exchange Commission
(“SEC”), including those factors discussed under the caption “Risk
Factors” in our most recent annual report on Form 10-K, filed with
the SEC on March 2, 2020, and in subsequent reports filed with or
furnished to the SEC, copies of which are available free of charge
within the Investor Relations section of the TRHC website
ir.trhc.com or upon request from our Investor Relations Department.
TRHC assumes no obligation and does not intend to update these
forward-looking statements, except as required by law, to reflect
events or circumstances occurring after today’s date.
Media ContactDianne Semingsondsemingson@TRHC.com
T: (215) 870-0829 |
Investors Frank Sparacino fsparacino@trhc.com T:
(866) 648-2767 |
|
|
Amanda Bednar abednar@trhc.com T:
(856) 912-5714 |
|
Tabula Rasa HealthCare (NASDAQ:TRHC)
Historical Stock Chart
From Feb 2024 to Mar 2024
Tabula Rasa HealthCare (NASDAQ:TRHC)
Historical Stock Chart
From Mar 2023 to Mar 2024